-+ 0.00%
-+ 0.00%
-+ 0.00%

HALOZYME THERAPEUTICS - INCYTE GRANTED RIGHTS TO DEVELOP ENHANZE WITH MUTCALR PROGRAM AND OPTION FOR TWO ADDITIONAL TARGETS

Reuters·07/20/2026 12:00:03

Please log in to view news